Together with other reports that GREM1 can activate epidermal growth factor (EGF) receptor in breast cancer cells (20, 34) and bind to slit guidance ligand-2 (SLIT2) in neurons, a somewhat muddied picture exists of GREM1 biology and signaling in health and disease. This evidence concerns the gene SLIT2 and breast carcinoma.